Alyssa Peckham

Alyssa Peckham

Mid Western University

H-index: 20

Asia-Nepal

About Alyssa Peckham

Alyssa Peckham, With an exceptional h-index of 20 and a recent h-index of 19 (since 2020), a distinguished researcher at Mid Western University, specializes in the field of Psychiatry, Substance Abuse.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pharmacist, prescriber, and drug policy expert opinions on gabapentinoid misuse

Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment

Low dose initiation of buprenorphine: a narrative review and practical approach

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 US states

State-level response to gabapentin misuse in the United States: Implications and future direction

Management of opioid agonist treatment for opioid use disorder in the setting of solid organ transplant

Comment on “Gabapentinoid benefit and risk stratification: mechanisms over myth”

Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: titration …

Alyssa Peckham Information

University

Position

Assistant Professor of Pharmacy Practice

Citations(all)

1159

Citations(since 2020)

1086

Cited By

352

hIndex(all)

20

hIndex(since 2020)

19

i10Index(all)

24

i10Index(since 2020)

24

Email

University Profile Page

Mid Western University

Google Scholar

View Google Scholar Profile

Alyssa Peckham Skills & Research Interests

Psychiatry

Substance Abuse

Top articles of Alyssa Peckham

Title

Journal

Author(s)

Publication Date

Pharmacist, prescriber, and drug policy expert opinions on gabapentinoid misuse

Jordan R Covvey

Michelle L Blakely

Reshmi Singh

Alyssa M Peckham

Kirk E Evoy

2023/4/1

Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment

Journal of Addiction Medicine

Jessica R Gray

Laura G Kehoe

Alyssa M Peckham

Sarah E Wakeman

2023/3/1

Low dose initiation of buprenorphine: a narrative review and practical approach

Shawn M Cohen

Melissa B Weimer

Ximena A Levander

Alyssa M Peckham

Jeanette M Tetrault

...

2022/2/8

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 US states

Drug and alcohol dependence

Lucas G Hill

Lindsey J Loera

Sorina B Torrez

Talia Puzantian

Kirk E Evoy

...

2022/8/1

State-level response to gabapentin misuse in the United States: Implications and future direction

American Journal of Health-System Pharmacy

Zoe A Karavolis

Andrew B Su

Alyssa M Peckham

2022/5/1

Management of opioid agonist treatment for opioid use disorder in the setting of solid organ transplant

Transplantation

Kayla Joyal

Alyssa M Peckham

Sarah E Wakeman

Daniel Zlotoff

Gregory D Lewis

...

2022/5/1

Comment on “Gabapentinoid benefit and risk stratification: mechanisms over myth”

Pain and therapy

Alyssa M Peckham

Jordan R Covvey

Kirk E Evoy

2021/6

Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: titration …

Substance Abuse

Jonathan P DeWeese

James R Krenz

Sarah E Wakeman

Alyssa M Peckham

2021/10

Antimicrobial Stewardship Can Help Prevent Injection Drug Use–Related Infections

Alyssa M Peckham

Michael G Chan

2021/4/22

Gabapentinoid pharmacology in the context of emerging misuse liability

Kirk E Evoy

Alyssa M Peckham

Jordan R Covvey

Kevin J Tidgewell

2021/8

Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts

Journal of Substance Abuse Treatment

Md Mahmudul Hasan

Md Noor-E-Alam

Prathamesh Mohite

Md Saiful Islam

Alicia Sasser Modestino

...

2021/12/1

Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic

American Journal of Health-System Pharmacy

Alyssa M Peckham

Jennifer Ball

Michelle D Colvard

David Dadiomov

Lucas G Hill

...

2021/4/1

Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample

International journal of clinical pharmacy

Kirk E Evoy

Jordan R Covvey

Alyssa M Peckham

Kelly R Reveles

2021/8/1

Prevalence of and factors associated with gabapentinoid use and misuse among Texas Medicaid recipients

Clinical Drug Investigation

Elizabeth A Ibiloye

Jamie C Barner

Kenneth A Lawson

Karen L Rascati

Kirk E Evoy

...

2021/3

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids

Mental Health Clinician

Payal H Desai

Olesya Taylor

Kunal J Shah

Kirk E Evoy

Alyssa M Peckham

2021/7/1

Abuse and misuse of pregabalin and gabapentin: a systematic review update

Kirk E Evoy

Sarvnaz Sadrameli

Jillian Contreras

Jordan R Covvey

Alyssa M Peckham

...

2021/1

Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: a retrospective case series

Journal of Substance Abuse Treatment

Alyssa M Peckham

Laura G Kehoe

Jessica R Gray

Sarah E Wakeman

2021/7/1

Diagnosis and treatment of ADHD in the United States: Update by gender and race

Journal of Attention Disorders

Kathleen A Fairman

Alyssa M Peckham

David A Sclar

2020/1

National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016

Journal of Substance Abuse Treatment

Kirk E Evoy

Laura Roccograndi

Samantha Le

Charles E Leonard

Jordan R Covvey

...

2020/12/1

Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women

Obstetrics & Gynecology

Erin M Cleary

R Kate Byron

Katherine A Hinely

Allison W Talley

Maged M Costantine

...

2020/11/1

See List of Professors in Alyssa Peckham University(Mid Western University)